These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 32544310)

  • 1. Further understanding the connection between Alzheimer's disease and Down syndrome.
    Snyder HM; Bain LJ; Brickman AM; Carrillo MC; Esbensen AJ; Espinosa JM; Fernandez F; Fortea J; Hartley SL; Head E; Hendrix J; Kishnani PS; Lai F; Lao P; Lemere C; Mobley W; Mufson EJ; Potter H; Zaman SH; Granholm AC; Rosas HD; Strydom A; Whitten MS; Rafii MS
    Alzheimers Dement; 2020 Jul; 16(7):1065-1077. PubMed ID: 32544310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease.
    Wilcock DM; Hurban J; Helman AM; Sudduth TL; McCarty KL; Beckett TL; Ferrell JC; Murphy MP; Abner EL; Schmitt FA; Head E
    Neurobiol Aging; 2015 Sep; 36(9):2468-74. PubMed ID: 26103884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvascular changes in Down syndrome with Alzheimer's-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer's disease.
    Drachman DA; Smith TW; Alkamachi B; Kane K
    Alzheimers Dement; 2017 Dec; 13(12):1389-1396. PubMed ID: 28627379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating Biomarker Outcomes into Clinical Trials for Alzheimer's Disease in Down Syndrome.
    Rafii MS; Zaman S; Handen BL
    J Prev Alzheimers Dis; 2021; 8(1):48-51. PubMed ID: 33336224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease.
    Helman AM; Siever M; McCarty KL; Lott IT; Doran E; Abner EL; Schmitt FA; Head E
    J Alzheimers Dis; 2019; 67(1):103-112. PubMed ID: 30452414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.
    Lao PJ; Handen BL; Betthauser TJ; Mihaila I; Hartley SL; Cohen AD; Tudorascu DL; Bulova PD; Lopresti BJ; Tumuluru RV; Murali D; Mathis CA; Barnhart TE; Stone CK; Price JC; Devenny DA; Johnson SC; Klunk WE; Christian BT
    J Alzheimers Dis; 2018; 61(2):631-644. PubMed ID: 29254096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease and Down's syndrome: treating two paths to dementia.
    Weksler ME; Szabo P; Relkin NR; Reidenberg MM; Weksler BB; Coppus AM
    Autoimmun Rev; 2013 Apr; 12(6):670-3. PubMed ID: 23201920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untangle the mystery behind DS-associated AD - Is APP the main protagonist?
    Elangovan A; Babu HWS; Iyer M; Gopalakrishnan AV; Vellingiri B
    Ageing Res Rev; 2023 Jun; 87():101930. PubMed ID: 37031726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Fortea J; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernández S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Alcolea D; Clarimón J; Zaman SH; Blesa R; Lleó A
    Lancet; 2020 Jun; 395(10242):1988-1997. PubMed ID: 32593336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common genetic signatures of Alzheimer's disease in Down Syndrome.
    Sharma A; Chunduri A; Gopu A; Shatrowsky C; Crusio WE; Delprato A
    F1000Res; 2020; 9():1299. PubMed ID: 33633844
    [No Abstract]   [Full Text] [Related]  

  • 11. PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome.
    Zammit MD; Tudorascu DL; Laymon CM; Hartley SL; Zaman SH; Ances BM; Johnson SC; Stone CK; Mathis CA; Klunk WE; Cohen AD; Handen BL; Christian BT
    Neuroimage; 2021 Mar; 228():117728. PubMed ID: 33421595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.
    Wilcock DM; Schmitt FA; Head E
    Biochim Biophys Acta; 2016 May; 1862(5):909-14. PubMed ID: 26593849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's disease.
    Martin SB; Dowling AL; Lianekhammy J; Lott IT; Doran E; Murphy MP; Beckett TL; Schmitt FA; Head E
    J Alzheimers Dis; 2014; 42(3):767-75. PubMed ID: 24927707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down syndrome and Alzheimer's disease: Common pathways, common goals.
    Hartley D; Blumenthal T; Carrillo M; DiPaolo G; Esralew L; Gardiner K; Granholm AC; Iqbal K; Krams M; Lemere C; Lott I; Mobley W; Ness S; Nixon R; Potter H; Reeves R; Sabbagh M; Silverman W; Tycko B; Whitten M; Wisniewski T
    Alzheimers Dement; 2015 Jun; 11(6):700-9. PubMed ID: 25510383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome.
    Moncaster JA; Pineda R; Moir RD; Lu S; Burton MA; Ghosh JG; Ericsson M; Soscia SJ; Mocofanescu A; Folkerth RD; Robb RM; Kuszak JR; Clark JI; Tanzi RE; Hunter DG; Goldstein LE
    PLoS One; 2010 May; 5(5):e10659. PubMed ID: 20502642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
    Chen XQ; Salehi A; Pearn ML; Overk C; Nguyen PD; Kleschevnikov AM; Maccecchini M; Mobley WC
    Alzheimers Dement; 2021 Feb; 17(2):271-292. PubMed ID: 32975365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down syndrome and Alzheimer's disease: a link between development and aging.
    Lott IT; Head E
    Ment Retard Dev Disabil Res Rev; 2001; 7(3):172-8. PubMed ID: 11553933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signalling Pathways Implicated in Alzheimer's Disease Neurodegeneration in Individuals with and without Down Syndrome.
    Martínez-Cué C; Rueda N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AT(N) biomarker profiles and Alzheimer's disease symptomology in Down syndrome.
    Hartley SL; Handen B; Tudorascu D; Lee L; Cohen A; Schworer EK; Peven JC; Zammit M; Klunk W; Laymon C; Minhas D; Luo W; Zaman S; Ances B; Preboske G; Christian BT;
    Alzheimers Dement; 2024 Jan; 20(1):366-375. PubMed ID: 37641428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose.
    Chen XQ; Zuo X; Becker A; Head E; Mobley WC
    Alzheimers Dement; 2023 May; 19(5):2095-2116. PubMed ID: 36370135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.